Sodium Phosphates (Hospira, Inc.)


Welcome to the PulseAid listing for the Sodium Phosphates drug offered from Hospira, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Hospira, Inc.
NON-PROPRIETARY NAME: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE and SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
SUBSTANCE NAME: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2005-06-02
END MARKETING DATE: 0000-00-00


Sodium Phosphates HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSodium Phosphates from Hospira, Inc.
LABELER NAME: Hospira, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 276; 142(mg/mL; mg/mL)
START MARKETING DATE: 2005-06-02
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0409-7391_c8cbcd2d-9d3a-470e-8201-00c24e7b85c7
PRODUCT NDC: 0409-7391
APPLICATION NUMBER: NDA018892

Other SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; SODIUM PHOSPHATE, DIBASIC, ANHYDROUS Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Cardinal HealthSodium Phosphates
Fresenius Kabi USA, LLCSodium Phosphates
Hospira, Inc.Sodium Phosphates
Salix Pharmaceuticals, Inc.OsmoPrep